Highlights:
– Management of type II endoleak divides the experts at CX35
– Intermittent claudication: Lack of funding for supervised exercise programmes remains a global problem
– First-in-man implantation of left subclavian artery branched TEVAR device
[pdfviewer width=”100%” height=”940px” beta=”true”]https://vascularnews.com/wp-content/uploads/sites/7/2016/02/58-Vascular-News.pdf[/pdfviewer]
